Search research articles
Contact Us
Filters
Showing results (81-90 of 120) with videos related to
Page
of 12
Sort By:
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
Radiology
|
February 24, 2021
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
Anton S Becker, Rocio Perez-Johnston, Sona A Chikarmane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
Siang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Breast Cancer Research : BCR
|
October 7, 2024
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H Armenian, Christina Lacchetti, Ana Barac, et al.
Breast Cancer Research and Treatment
|
November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
Nancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Journal of the National Cancer Institute
|
May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer
Guilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 120) with videos related to
Sort By:
Page
of 12
Clinical Breast Cancer
|
January 31, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials
Dario Trapani, Qingchun Jin, Kathy D Miller, et al.
Radiology
|
February 24, 2021
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
Anton S Becker, Rocio Perez-Johnston, Sona A Chikarmane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2021
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer
Siang-Boon Koh, Kenneth Ross, Steven J Isakoff, et al.
Breast Cancer Research : BCR
|
October 7, 2024
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2016
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H Armenian, Christina Lacchetti, Ana Barac, et al.
Breast Cancer Research and Treatment
|
November 8, 2013
A phase I study of lapatinib with whole brain radiotherapy in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer brain metastases
Nancy U Lin, Rachel A Freedman, Naren Ramakrishna, et al.
Journal of the National Cancer Institute
|
May 19, 2026
Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer
Guilherme Nader-Marta, Yue Zheng, Shoshana M Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2020
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Nadine Tung, Banu Arun, Michele R Hacker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 12, 2019
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR<sup>+</sup> Metastatic Triple-Negative Breast Cancer
Brian D Lehmann, Vandana G Abramson, Melinda E Sanders, et al.
Page
of 12